Drug Interactions between Sensipar and Seromycin Pulvules
This report displays the potential drug interactions for the following 2 drugs:
- Sensipar (cinacalcet)
- Seromycin Pulvules (cycloserine)
Interactions between your drugs
No interactions were found between Sensipar and Seromycin Pulvules. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Sensipar
A total of 158 drugs are known to interact with Sensipar.
- Sensipar is in the drug class calcimimetics.
- Sensipar is used to treat the following conditions:
Seromycin Pulvules
A total of 42 drugs are known to interact with Seromycin Pulvules.
- Seromycin pulvules is in the drug class streptomyces derivatives.
- Seromycin pulvules is used to treat the following conditions:
Drug and food interactions
cycloSERINE food
Applies to: Seromycin Pulvules (cycloserine)
GENERALLY AVOID: Coadministration with alcohol may potentiate some of the central nervous system adverse effects of cycloserine and its prodrug, terizidone. These effects may include dizziness, drowsiness, depression, anxiety, psychoses, memory impairment, confusion, and convulsions.
MANAGEMENT: Patients should be advised to avoid the consumption of alcohol during treatment with cycloserine or terizidone. The use of these medications is contraindicated in patients with chronic alcohol consumption or alcoholism.
MONITOR CLOSELY: Coadministration with caffeine may potentiate some of the central nervous system adverse effects of cycloserine and its prodrug, terizidone. These effects may include insomnia, excitability, irritability, anxiety, tremor, psychoses, and convulsions.
MANAGEMENT: Caution is advised when cycloserine or terizidone is used with caffeine. Consumption of certain beverages or stimulants with very high caffeine levels should be avoided as a precautionary measure.
References (2)
- (2001) "Product Information. Seromycin (cycloserine)." Dura Pharmaceuticals
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
cinacalcet food
Applies to: Sensipar (cinacalcet)
ADJUST DOSING INTERVAL: Food enhances the oral absorption and bioavailability of cinacalcet. According to the product labeling for cinacalcet, administration with a high-fat meal increased the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of cinacalcet by 82% and 68%, respectively, compared to administration in the fasting state. The Cmax and AUC were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared to fasting.
MANAGEMENT: To ensure maximal oral absorption, cinacalcet should be administered with or immediately after a meal. The tablets should be taken whole and not divided or crushed.
References (1)
- (2004) "Product Information. Sensipar (cinacalcet)." Amgen USA
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.